CDC25B and acute myeloid leukemia: To confirm binding of IER5 to the Cdc25B promoter and more accurately define its binding site, we performed ChIP analysis in AML cells using two pairs of oligonucleotides within upstream from the transcription start site for Cdc25B (Fig. 4B).